
Audrey Cacaly MSc
Principal
Noema Pharma's pipeline contains novel therapies designed to address debilitating central nervous system (CNS) disorders in order to improve quality of life and patient outcomes.
The company partners with patients, families and caregivers, and healthcare professionals to provide a comprehensive approach beyond treating symptoms to ensure that patients’ experiences, perspectives, needs, and priorities are meaningfully incorporated into our work.
Industry
Biotech
Status
Current